US Stock MarketDetailed Quotes

ResMed (RMD)

Watchlist
  • 202.370
  • -1.420-0.70%
Close May 13 16:00 ET
  • 201.770
  • 0.0000.00%
Pre 04:00 ET
29.36BMarket Cap19.51P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ResMed (RMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2026
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
Total revenue
10.81%1.43B
10.98%1.42B
9.07%1.34B
9.84%5.15B
10.20%1.35B
7.92%1.29B
10.26%1.28B
11.08%1.22B
10.95%4.69B
9.01%1.22B
Operating revenue
10.81%1.43B
10.98%1.42B
9.07%1.34B
9.84%5.15B
10.20%1.35B
7.92%1.29B
10.26%1.28B
11.08%1.22B
10.95%4.69B
9.01%1.22B
Cost of revenue
2.87%540.43M
2.50%544.08M
1.47%514.76M
3.02%2.09B
3.99%527.93M
4.19%525.33M
2.90%530.81M
1.00%507.29M
8.71%2.03B
0.59%507.67M
Gross profit
16.25%890.98M
16.96%878.72M
14.44%820.82M
15.05%3.05B
14.61%820.07M
10.63%766.41M
16.13%751.28M
19.52%717.22M
12.72%2.66B
15.90%715.53M
Operating expense
15.00%391.17M
14.10%381.13M
8.66%358.47M
7.58%1.37B
8.73%363.5M
6.90%340.14M
8.59%334.03M
6.06%329.91M
5.61%1.27B
0.95%334.31M
Selling and administrative expenses
16.45%285.66M
15.22%278.4M
8.46%259.19M
8.06%991.02M
9.47%265.13M
6.69%245.3M
8.76%241.61M
7.23%238.98M
4.94%917.14M
0.62%242.19M
Research and development costs
12.30%94.27M
11.79%90.97M
9.81%87.32M
7.73%331.28M
6.90%86.44M
8.91%83.94M
10.14%81.37M
5.04%79.52M
6.91%307.53M
3.48%80.86M
Depreciation amortization depletion
3.23%11.25M
6.49%11.76M
4.84%11.96M
-2.68%45.27M
5.91%11.93M
-2.76%10.9M
-4.58%11.05M
-8.61%11.4M
10.71%46.52M
-8.58%11.26M
-Depreciation and amortization
3.23%11.25M
6.49%11.76M
4.84%11.96M
-2.68%45.27M
5.91%11.93M
-2.76%10.9M
-4.58%11.05M
-8.61%11.4M
10.71%46.52M
-8.58%11.26M
Operating profit
17.25%499.81M
19.26%497.6M
19.37%462.35M
21.91%1.69B
19.77%456.57M
13.80%426.27M
22.96%417.24M
34.02%387.31M
20.15%1.38B
33.18%381.22M
Net non-operating interest income expense
1,449.43%12.29M
1,125.68%7.95M
629.38%8.79M
109.00%4.11M
197.23%5.76M
107.19%793K
94.39%-775K
88.89%-1.66M
3.53%-45.71M
60.38%-5.92M
Non-operating interest expense
----
----
----
----
----
----
----
----
-3.53%45.71M
----
Total other finance cost
-1,449.43%-12.29M
-1,125.68%-7.95M
-629.38%-8.79M
-109.00%-4.11M
-197.23%-5.76M
-107.19%-793K
-94.39%775K
-88.89%1.66M
-3.53%45.71M
-60.38%5.92M
Other net income (expense)
-4.45%-9.79M
-606.80%-9.4M
-1,030.32%-24.35M
81.06%-13.94M
75.66%-4.28M
-178.97%-9.37M
102.81%1.85M
-16.50%-2.15M
-2,392.04%-73.62M
-418.92%-17.56M
Earnings from equity interest
-58.36%-8.41M
603.04%1.82M
-1,761.13%-4.7M
-12.93%-6.66M
91.34%-1.27M
-136.99%-5.31M
68.49%-362K
106.29%283K
-321.79%-5.89M
-283.16%-14.61M
Special income (charges)
--0
---5.94M
---15.81M
96.84%-2.03M
---2.03M
--0
--0
--0
-63,692.08%-64.23M
--0
-Less：Restructuring and merger&acquisition
--0
--5.94M
--15.81M
-96.84%2.03M
--2.03M
--0
--0
--0
219.13%64.23M
--0
Other non- operating income (expenses)
66.15%-1.37M
-338.36%-5.28M
-57.41%-3.84M
-50.43%-5.26M
66.89%-979K
-62.50%-4.06M
423.03%2.22M
-192.03%-2.44M
38.83%-3.49M
-4,947.54%-2.96M
Income before tax
20.26%502.31M
18.60%496.15M
16.50%446.79M
32.64%1.68B
28.04%458.05M
11.26%417.69M
61.23%418.32M
40.89%383.5M
14.81%1.26B
29.24%357.73M
Income tax
96.73%103.58M
40.51%103.56M
36.20%98.26M
13.53%276.84M
19.62%78.35M
-29.73%52.65M
45.50%73.7M
36.71%72.14M
19.47%243.85M
38.95%65.5M
Net income
9.23%398.73M
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
Net income continuous Operations
9.23%398.73M
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
Minority interest income
Net income attributable to the parent company
9.23%398.73M
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.23%398.73M
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
Basic earnings per share
10.04%2.74
14.47%2.69
12.26%2.38
37.61%9.55
30.15%2.59
22.06%2.49
65.49%2.35
42.28%2.12
13.40%6.94
27.56%1.99
Diluted earnings per share
10.48%2.74
14.53%2.68
12.32%2.37
37.43%9.51
30.30%2.58
21.57%2.48
64.79%2.34
41.61%2.11
13.63%6.92
26.92%1.98
Dividend per share
13.21%0.6
13.21%0.6
13.21%0.6
10.42%2.12
10.42%0.53
10.42%0.53
10.42%0.53
10.42%0.53
9.09%1.92
9.09%0.48
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2026(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024
Total revenue 10.81%1.43B10.98%1.42B9.07%1.34B9.84%5.15B10.20%1.35B7.92%1.29B10.26%1.28B11.08%1.22B10.95%4.69B9.01%1.22B
Operating revenue 10.81%1.43B10.98%1.42B9.07%1.34B9.84%5.15B10.20%1.35B7.92%1.29B10.26%1.28B11.08%1.22B10.95%4.69B9.01%1.22B
Cost of revenue 2.87%540.43M2.50%544.08M1.47%514.76M3.02%2.09B3.99%527.93M4.19%525.33M2.90%530.81M1.00%507.29M8.71%2.03B0.59%507.67M
Gross profit 16.25%890.98M16.96%878.72M14.44%820.82M15.05%3.05B14.61%820.07M10.63%766.41M16.13%751.28M19.52%717.22M12.72%2.66B15.90%715.53M
Operating expense 15.00%391.17M14.10%381.13M8.66%358.47M7.58%1.37B8.73%363.5M6.90%340.14M8.59%334.03M6.06%329.91M5.61%1.27B0.95%334.31M
Selling and administrative expenses 16.45%285.66M15.22%278.4M8.46%259.19M8.06%991.02M9.47%265.13M6.69%245.3M8.76%241.61M7.23%238.98M4.94%917.14M0.62%242.19M
Research and development costs 12.30%94.27M11.79%90.97M9.81%87.32M7.73%331.28M6.90%86.44M8.91%83.94M10.14%81.37M5.04%79.52M6.91%307.53M3.48%80.86M
Depreciation amortization depletion 3.23%11.25M6.49%11.76M4.84%11.96M-2.68%45.27M5.91%11.93M-2.76%10.9M-4.58%11.05M-8.61%11.4M10.71%46.52M-8.58%11.26M
-Depreciation and amortization 3.23%11.25M6.49%11.76M4.84%11.96M-2.68%45.27M5.91%11.93M-2.76%10.9M-4.58%11.05M-8.61%11.4M10.71%46.52M-8.58%11.26M
Operating profit 17.25%499.81M19.26%497.6M19.37%462.35M21.91%1.69B19.77%456.57M13.80%426.27M22.96%417.24M34.02%387.31M20.15%1.38B33.18%381.22M
Net non-operating interest income expense 1,449.43%12.29M1,125.68%7.95M629.38%8.79M109.00%4.11M197.23%5.76M107.19%793K94.39%-775K88.89%-1.66M3.53%-45.71M60.38%-5.92M
Non-operating interest expense ---------------------------------3.53%45.71M----
Total other finance cost -1,449.43%-12.29M-1,125.68%-7.95M-629.38%-8.79M-109.00%-4.11M-197.23%-5.76M-107.19%-793K-94.39%775K-88.89%1.66M-3.53%45.71M-60.38%5.92M
Other net income (expense) -4.45%-9.79M-606.80%-9.4M-1,030.32%-24.35M81.06%-13.94M75.66%-4.28M-178.97%-9.37M102.81%1.85M-16.50%-2.15M-2,392.04%-73.62M-418.92%-17.56M
Earnings from equity interest -58.36%-8.41M603.04%1.82M-1,761.13%-4.7M-12.93%-6.66M91.34%-1.27M-136.99%-5.31M68.49%-362K106.29%283K-321.79%-5.89M-283.16%-14.61M
Special income (charges) --0---5.94M---15.81M96.84%-2.03M---2.03M--0--0--0-63,692.08%-64.23M--0
-Less：Restructuring and merger&acquisition --0--5.94M--15.81M-96.84%2.03M--2.03M--0--0--0219.13%64.23M--0
Other non- operating income (expenses) 66.15%-1.37M-338.36%-5.28M-57.41%-3.84M-50.43%-5.26M66.89%-979K-62.50%-4.06M423.03%2.22M-192.03%-2.44M38.83%-3.49M-4,947.54%-2.96M
Income before tax 20.26%502.31M18.60%496.15M16.50%446.79M32.64%1.68B28.04%458.05M11.26%417.69M61.23%418.32M40.89%383.5M14.81%1.26B29.24%357.73M
Income tax 96.73%103.58M40.51%103.56M36.20%98.26M13.53%276.84M19.62%78.35M-29.73%52.65M45.50%73.7M36.71%72.14M19.47%243.85M38.95%65.5M
Net income 9.23%398.73M13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M
Net income continuous Operations 9.23%398.73M13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M
Minority interest income
Net income attributable to the parent company 9.23%398.73M13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.23%398.73M13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M
Basic earnings per share 10.04%2.7414.47%2.6912.26%2.3837.61%9.5530.15%2.5922.06%2.4965.49%2.3542.28%2.1213.40%6.9427.56%1.99
Diluted earnings per share 10.48%2.7414.53%2.6812.32%2.3737.43%9.5130.30%2.5821.57%2.4864.79%2.3441.61%2.1113.63%6.9226.92%1.98
Dividend per share 13.21%0.613.21%0.613.21%0.610.42%2.1210.42%0.5310.42%0.5310.42%0.5310.42%0.539.09%1.929.09%0.48
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -